Challenges you face finding relatively low risk / high return innovation
Start-ups often bring either technical strength or management strength, but both are needed to achieve success
While significant amounts of technical data are typically available, hard evidence demonstrating competitive advantage is often lacking
New technologies typically have patents applied for, and some potentially granted, yet value is only created when claims are granted for points of competitive advantage
Scaling up production from a few proof-of-concept units to hundreds to thousands to millions presents many start-ups with significant challenges maintaining quality/consistency, managing capital projects and meeting cost of goods targets
Every business plan has pro forma financial projections, but many times key assumptions are based on management estimates, not market-based evidence
What Genacept brings to you: market-changing innovation with technical and business risks mitigated by data and discipline
Both technical and management capabilities, with a disciplined, comprehensive planning process
Intellectual property focused on key elements of competitive advantage
Supply chain established with experienced partners and documentation supporting capital requirements and cost of goods
Pro forma financial projections with key assumptions supported by market data